ActiveNANCT03466476

Evaluating the Efficacy of the TracPatch Wearable Technology on Patients Undergoing Total Knee Arthroplasty (TKA)

Sponsor: University of Miami

Trial Details

Condition	Arthroplasty, Replacement, Knee, Osteoarthritis, Knee
Intervention	Consensus TracPatch
Phase	NA
Status	Active
Participants	150
Est. Completion	1 June 2027
Last Updated	12 June 2026

Primary Outcome

Range of Motion

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Surgical candidate for total knee arthroplasty * Greater than 18 years of age * Have signed the written informed consent form * Have consistent access to an iOS or Android device with Bluetooth capability Exclusion Criteria: * Unwilling or unable to provide consent * Not fluent in the language of the informed consent form (English and Spanish) * Prisoners * Pregnant women * Wards of the state * Have previously undergone a TKA on that ipsilateral knee * Deformities of \> 10 degrees valgus or varus or flexion contractures of \> 10 degrees. * Considered by the surgeon to be a complex arthroplasty

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

TracPatch Wearable Technology Trial in Total Knee Arthroplasty: Real-Time Recovery Monitoring for Enhanced Rehabilitation Outcomes

New trial evaluates TracPatch wearable technology for continuous post-operative monitoring in total knee arthroplasty patients. The device tracks mobility, temperature, and activity to potentially improve rehabilitation outcomes and patient-physician communication.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service